<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[23andMe Stories - Medium]]></title>
        <description><![CDATA[23 pairs of chromosomes. One unique you. - Medium]]></description>
        <link>https://medium.com/23andme-stories?source=rss----5ff813981120---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>23andMe Stories - Medium</title>
            <link>https://medium.com/23andme-stories?source=rss----5ff813981120---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 23:24:41 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/23andme-stories" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[New Year, New You: Three Stories of Change]]></title>
            <link>https://medium.com/23andme-stories/new-year-new-you-three-stories-of-change-b7bd27bafcf2?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/b7bd27bafcf2</guid>
            <category><![CDATA[healthy-lifestyle]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[habits]]></category>
            <category><![CDATA[resolutions]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Wed, 18 Jan 2023 02:29:28 GMT</pubDate>
            <atom:updated>2023-01-05T19:53:10.188Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*5EuoSoHzXCY-5neBiQv9bA.png" /></figure><p>On January 1, many of us resolve to change our habits. We vow to move more, sit less, eat better, lose weight, spend wisely, call our mothers, or start a new hobby.</p><p>Setting New Year’s resolutions can be a valuable exercise:<a href="https://onlinelibrary.wiley.com/doi/10.1002/jclp.1151"> research</a> shows that the act of making them increases the likelihood of achieving change.</p><p>Whatever your goals are for the new year, here are three stories of 23andMe customers who made positive changes in their lives to inspire and motivate.</p><h4><a href="https://blog.23andme.com/articles/a-family-gets-healthy-with-some-help-from-mom">A Family Gets Healthy, with Some Help from Mom</a></h4><p><a href="https://blog.23andme.com/articles/a-family-gets-healthy-with-some-help-from-mom">Corie Allessie</a>, a retired dental assistant and former Navy jet mechanic, has a few essential rules for healthy living.Never, ever eat in front of the television. Get up and get moving (winter is <em>not </em>an excuse). Prepare healthy food — especially vegetables — ahead of time. Minimize eating out. Walk whenever you can (her preferred walking partner is her 170-pound Saint Bernard, Pete). And keep yourself accountable by writing in a journal or sharing your goals with a friend or family member.</p><h4><a href="https://blog.23andme.com/articles/healthier-every-day">From Meat and Potatoes to Chicken and Fish</a></h4><p><a href="https://blog.23andme.com/articles/healthier-every-day">Erick Rodriguez</a>, a professional Jiu-Jitsu athlete in the Army reserves, grew up in the Midwest and never thought much about his diet. But the self-proclaimed “meat and potatoes guy” overhauled his lifestyle after learning he was at an increased likelihood of developing type 2 diabetes.</p><h4><a href="https://blog.23andme.com/articles/23andme-heart-health">Making the Change</a></h4><p><a href="https://blog.23andme.com/articles/23andme-heart-health">Kim Gugliotta</a> fills her plate with healthy foods like legumes, vegetables, chicken, fish, and tofu. She walks for at least 30 minutes a day. And she’s a regular on the pickleball courts of Ft. Lauderdale, Fl.</p><p>But Kim wasn’t always so health conscious. Just a few years ago, she would have opted for “steak and cheeseburgers” and would have been tempted to skip her daily walk.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b7bd27bafcf2" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/new-year-new-you-three-stories-of-change-b7bd27bafcf2">New Year, New You: Three Stories of Change</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Celebrating MLK Day as a Black Leader in Tech]]></title>
            <link>https://medium.com/23andme-stories/celebrating-mlk-day-as-a-black-leader-in-tech-20ccf787b732?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/20ccf787b732</guid>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Wed, 18 Jan 2023 02:28:43 GMT</pubDate>
            <atom:updated>2023-01-16T14:01:53.404Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Kim Noel, MD, Medical Director, 23andMe Healthcare Operations</em></p><p>For the past five years, every Martin Luther King Jr. Day I’ve learned something new. I used to think of it as a “day off”; national holidays are usually passive celebrations motivated by paid work leave. But, MLK Day has taken on new significance, especially in the past few years as national consciousness of racial injustice has resurfaced.</p><p>Being in the elite world of tech during this social movement has been an interesting challenge because so many here seem oblivious that the racial injustice and structural racism they condemn elsewhere is also part of their world . Absent dire circumstances, it is sometimes hard to grasp the intricacies of structural racism. However, even in the shiny Silicon Valley, we don’t escape reality (Worth reading “<a href="https://hbr.org/2021/03/what-its-like-to-be-a-black-man-in-tech">What it is like to be a black man in Tech” in Harvard Business Review</a> if unfamiliar). MLK Day here, and in this new age has become an opportunity for self-education, learning more about the complexities of a glorified man’s approach to tackle a violent and unresolved fight for racial and social equity.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_QKQmv2GaGZQUmEi9ouOMg.jpeg" /><figcaption>Dr. Kim Noel, <em>Medical Director, 23andMe Healthcare Operations</em></figcaption></figure><p>I am always surprised about what I learn on MLK Day. This year I learned that although a national holiday, MLK Day was not uniformly celebrated nationally. Despite being signed into law by Reagan in 1983, it was only in 2020, that Virginia separated the holiday from Lee-Jackson Day, in which the holiday was reluctantly lumped in with the celebration of confederate generals. I also learned that South Carolina didn’t accept the holiday until 2000. I was reminded that the very existence of the holiday came through struggle. That MLK Day legislation did not originally pass, as it was deemed “too expensive, and inappropriate in honoring a private citizen who never held public office” with taxpayer dollars. That legislation declaring a national holiday was forced, with a petition of six million signatures.It was one of the largest petitions in favor of an issue in U.S history, according to a 2006 article in <em>The Nation</em>.</p><p>I am also somehow always a bit ashamed of how little I know of black history, even having always been a good student with an elite education. I am excited to learn more. I’m excited to see new stories featuring black characters being portrayed in Hollywood and the media. (The movie Woman King definitely led me to read all about the Agojie warriors.) But entertainment aside, I realize that my ignorance about some black history is part of a broader problem in how we teach history. It tends to be myopic, or in the case of Dr. King, reductionist, portraying him simply as the “man with a dream.”</p><p>Dr. King had a dream, but he also wrote:</p><p>“We are not makers of history. We are made by history, and that many of the ugly pages of American history have been obscured and forgotten . . . America owes a debt of justice which it has only begun to pay.”</p><p>It is that imbalance of justice that continues to thrive today, that’s what makes Dr. King still so relevant today. I must make a full disclosure, that in dark times I tend to read depressing historical accounts. I believe it helps me put our current struggles into context, but it also teaches me about strength and survival amid difficult times.</p><p>In the wake of George Floyd’s murder, the racial unrest that followed and the ongoing pandemic in 2020, I ended up reading historical biographies of slavery, apartheid, the U.S prison system, 1918 flu, and the Holocaust. I wanted to absorb all the resilience I could from the heroes who fought oppression and desolation during those times.</p><p>I also remember the first MLK Day and Black History Month almost one year after George Flloyd in 2021, when the world seemed too festive for my liking. Too much emphatic corporate sponsorship without being accountable to true social change and not enough acknowledgment of history. I craved a deeper understanding of the history of Dr. King that year, because I feel we have been too keen on focusing on the celebration of unity, and not keen enough in understanding the foundational elements of structural racism which were a core component of Dr. King’s work. MLK Day is a reminder that Dr. King’s job was left incomplete, and the day of celebration is a call for us to pause from our day jobs and get working on our self-education.</p><p>As a leader at 23andMe, where we are lovingly thought of as an activist brand, I hope that our company embraces the corporate enthusiasm of celebrating MLK Day, and inspires review of his full work. My wish is that MLK Day be a day of reflection that does not shy away from our shared violent history of slavery and racial injustice, a history that continues to thwart our goals of equity to this day. I hope that in these moments of reflection, we view these black heroes in the proper historical context, to understand their true exceptional strength. For MLK Day this year I celebrate his power of resilience and love despite oppression.</p><p>Dr. King wrote: “ Darkness cannot drive out darkness; only light can do that. Hate cannot drive out hate; only love can do that.”</p><p>May we celebrate Dr. King for enlightening the darkened path, as we take a day to rest, be with loved ones and hopefully to self-educate.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=20ccf787b732" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/celebrating-mlk-day-as-a-black-leader-in-tech-20ccf787b732">Celebrating MLK Day as a Black Leader in Tech</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Gift of Health, via a Gluten-Free Diet]]></title>
            <link>https://medium.com/23andme-stories/the-gift-of-health-via-a-gluten-free-diet-b8f9e7b59c6e?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/b8f9e7b59c6e</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[gluten-free]]></category>
            <category><![CDATA[celiac-disease]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Wed, 18 Jan 2023 02:27:47 GMT</pubDate>
            <atom:updated>2023-01-18T02:27:25.637Z</atom:updated>
            <content:encoded><![CDATA[<p>Out with the gluten, in with the gluten-free substitutes.</p><p>That’s the new motto for Brandon Moore, who was recently diagnosed with celiac disease.</p><p><strong>Unexplained symptoms</strong></p><p>Brandon never knew that all the pizza, pasta, and bread that sustained him were also making him ill.</p><p>He’d experienced chronic stomach problems for as long as he could remember, but no doctor or specialist could explain them. “I have done multiple tests looking for various issues like diverticulitis and stomach ulcers,” he said. “My doctors never found anything.”</p><p>Then he received a 23andMe Health + Ancestry kit as a gift from his step-grandmother. His <a href="https://blog.23andme.com/articles/new-23andme-report-celiac-disease">23andMe Celiac Disease Genetic Health Risk report*</a> indicated that he had a slightly increased risk of developing celiac disease.</p><p>He mentioned his results to his doctor during a routine physical, who ordered a follow-up test. The results confirmed he had the condition.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*W5NFSaC9ONsz8RRf4igF9Q.jpeg" /></figure><p><strong>A new lifestyle</strong></p><p><a href="https://www.23andme.com/topics/health-predispositions/celiac-disease/">Celiac disease</a> is an autoimmune condition in which the consumption of gluten protein — found in wheat and other grains like barley and rye — can result in damage to the small intestine and cause digestive and non-digestive symptoms.</p><p>The only known treatment is a gluten-free diet. So, Brandon began reading labels and avoiding everything containing gluten.</p><p>Within weeks of going gluten-free, he felt better. His chronic stomach problems abated. And he even began to lose weight. “I feel physically and mentally healthier than I have ever felt in my life,” he said. “I lost 50 pounds; I don’t even get colds anymore!”</p><p>Brandon has adjusted to his new gluten-free lifestyle. “I don’t take a lot of risks. It’s just not worth it,” he said. “Even a minuscule amount of gluten will upset my stomach.”</p><p>He credits his success to his wife, who helps him research and prepare food: “I couldn’t do it without her. She is my rock.”</p><p>He also enjoys introducing his friends to the wide array of gluten-free products that are now available. “We’ll have friends over, and we’ll prepare them hamburgers on gluten-free buns, and honestly, they don’t even know the difference. Everything’s pretty good now!”</p><p><em>*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. The Celiac Disease Genetic Health Risk report (i) is indicated for reporting of the rs2187668 variant in the HLA-DQA1 gene, which tags the HLA-DQ2.5 haplotype, and the rs7454108 variant near the HLA-DQB1 gene, which tags the HLA-DQ8 haplotype and (ii) describes if a person has variants associated with a higher risk of developing celiac disease. The variants included in this report are common in many ethnicities, but are best studied in people of European descent.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b8f9e7b59c6e" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/the-gift-of-health-via-a-gluten-free-diet-b8f9e7b59c6e">The Gift of Health, via a Gluten-Free Diet</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Year in Genetics]]></title>
            <link>https://medium.com/23andme-stories/the-year-in-genetics-6d84da0bdbda?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/6d84da0bdbda</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[discovery]]></category>
            <category><![CDATA[genetics]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Tue, 03 Jan 2023 19:11:30 GMT</pubDate>
            <atom:updated>2023-01-03T19:11:30.808Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3R_MutwgdFWYd3N2NsqsyQ.png" /></figure><p>The past year in genetics has held no shortage of surprises. Fossilized bone fragments helped to rewrite parts of the Neanderthal story, including how some bands migrated and lived. A team of researchers in Spain learned that doppelgangers have more in common than meets the eye. The phrase “superdodger” officially entered the COVID-19 lexicon. And new analysis confirmed what anyone who’s ever hit a dance floor already knows–the ability to move in time to a beat is partly genetic.</p><p>From big discoveries that moved the field forward to work that improved upon existing findings, here are some of the year’s milestones.</p><p><strong>A Neanderthal family portrait</strong></p><p>Deep inside a cave in southern Siberia, a team of researchers<a href="https://www.nature.com/articles/d41586-022-03339-7"> discovered</a> the fossilized bone fragments of the first-known Neanderthal family.</p><p>DNA analysis of these fragments offered rare insights into Neanderthals’ lives — depicting their social structures, migratory patterns, and relationships.</p><p><strong>Are you a superdodger?</strong></p><p>In 2022, a new term entered the COVID-19 lexicon: superdodger. A superdodger is someone who appears to have avoided COVID infection despite multiple exposures to new variants and waves.</p><p>Scientists were so puzzled by these virus evaders they began to look for<a href="https://www.npr.org/sections/goatsandsoda/2022/09/07/1121599445/so-you-havent-caught-covid-yet-does-that-mean-youre-a-superdodger"> genetic clues</a>. Research out of UCSF revealed a genetic variant in a gene called HLA that clears the virus rapidly. “The immune response gets just kind of fired up much more quickly,”<a href="https://www.npr.org/2022/09/28/1125525805/what-science-has-to-say-about-so-called-covid-superdodgers"> explained</a> Jill Hollenbach, an immunogeneticist at UCSF. “So that you basically nuke the infection before you even start to have symptoms.”</p><p><strong>More than a look-alike</strong></p><p>Your doppelganger may share more than just your physical characteristics–they may also share similar DNA.</p><p>Researchers in Spain compared and analyzed the DNA of doppelgangers who had participated in a photography series on look-alikes by Canadian artist François Brunelle. They<a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01075-0"> found</a> that people with very similar faces also shared many of the same genetic variants.</p><p><strong>You’ve got the music in you</strong></p><p>When your favorite song comes on the radio, can you tap, clap, and dance in time to its beat?</p><p>Researchers at Vanderbilt University and 23andMe<a href="https://blog.23andme.com/articles/we-got-the-beat"> found</a> more than 60 genetic links to the ability to move in time to musical rhythm — an important first step in understanding the genetic architecture of musicality.</p><p><strong>Polygenic risk scores go mainstream</strong></p><p>Polygenic risk scores, DNA-based tools that enhance our ability to predict the risk of common diseases, made headlines this year. Researchers worldwide developed new scores for common conditions like t<a href="https://www.frontiersin.org/articles/10.3389/fgene.2022.871260/full?&amp;utm_source=Email_to_authors_&amp;utm_medium=Email&amp;utm_content=T1_11.5e1_author&amp;utm_campaign=Email_publication&amp;field=&amp;journalName=Frontiers_in_Genetics&amp;id=871260">ype 2 diabetes</a>, <a href="https://consumer.healthday.com/polygenic-risk-score-predicts-risk-of-hip-knee-replacement-2657254383.html">knee and hip osteoarthritis</a>, <a href="https://www.ahajournals.org/doi/epdf/10.1161/CIR.0000000000001077">cardiovascular disease</a>, <a href="https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2798369">glaucoma</a>, and <a href="https://www.nature.com/articles/s41588-022-01074-3">more</a>. Here at 23andMe, researchers developed scores that formed the basis for 12 new <a href="https://www.23andme.com/dna-reports-list/">reports</a>.</p><p>All of this work suggests that we’re closer than ever to realizing the promise of polygenic risk scores. As risk prediction continues to improve, these tools can be used to inform treatment decisions, guide lifestyle modifications, and influence disease screening.</p><p><strong>Francis Collins’ next act</strong></p><p>After more than 12 years as the director of the NIH, physician-geneticist Dr. Francis Collins <a href="https://www.nih.gov/farewell-dr-francis-collins">announced</a> he would step down to return to his lab at the National Human Genome Research Institute and join President Biden’s administration as an <a href="https://nihrecord.nih.gov/2022/03/18/collins-named-acting-science-advisor-president-biden#:~:text=16%2C%20the%20White%20House%20announced,science%20advisor%20to%20President%20Biden.">acting science adviser</a>.</p><p>Dr. Collins brought his diplomatic skills and expertise to the job of NIH director. Highlights of his tenure include co-launching the Cancer Moonshot Initiative, which aims to speed progress in cancer research and prevention, navigating the COVID-19 pandemic, and supporting research for mRNA vaccines.</p><p><strong>A new era of drug discovery</strong></p><p>A 2022 <a href="https://www.nature.com/articles/d41573-022-00120-3">study</a> found that 33 of the 50 drugs recently approved by the Food and Drug Administration were supported with genomic data — making it clear that genetic insights will play an increasingly important role in developing new therapies for people who need them most.</p><p>23andMe has long <a href="https://blog.23andme.com/articles/drug-discovery-explained">envisioned</a> a model of drug discovery fueled by human genetics. This year, we moved closer to making that a reality. Our therapeutics team recently initiated a <a href="https://blog.23andme.com/articles/more-on-23andmes-first-clinical-trial-of-a-potential-new-cancer-treatment">Phase 1 clinical trial </a>for a potential new cancer treatment, an immunotherapy antibody called 23ME-00610.</p><p><strong>Tall order</strong></p><p>The <a href="https://blog.23andme.com/articles/height-gwas">largest genome-wide association study</a> ever done found nearly all the common genetic variants that explain the heritability of height among people of European ancestry, and, in the process, may have set the framework for future genetic research into other traits and diseases.</p><p>Using data from about 5.4 million individuals, almost half of whom were 23andMe customers who consented to participate in research, the GIANT study identified 12,111 variants that help explain 10 to 40 percent of all variation in height, depending on a person’s ancestry. They cluster around parts of the genome involved in skeletal growth.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6d84da0bdbda" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/the-year-in-genetics-6d84da0bdbda">The Year in Genetics</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[A Sister’s Gift]]></title>
            <link>https://medium.com/23andme-stories/a-sisters-gift-f099194e9829?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/f099194e9829</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[genetics]]></category>
            <category><![CDATA[medical-mysteries]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Wed, 21 Dec 2022 00:41:19 GMT</pubDate>
            <atom:updated>2022-12-21T00:41:12.204Z</atom:updated>
            <content:encoded><![CDATA[<p>Like all good Christmas stories, this one begins with a gift.</p><p>Kathy Clemenzi’s son gave her a 23andMe Health + Ancestry Kit for the holidays. He thought that Kathy, the self-appointed “family historian,” might enjoy using the kit to learn more about their ancestry and confirm some family stories passed down through the generations.</p><p>It was the perfect present.</p><p>“I’m always the one that looks into all the genealogy things and shares all the stories,” Kathy explained. “I even found out I’m 80 percent British and Irish — more than I expected!”</p><p><strong>A medical mystery</strong></p><p>Diving into her family history provided a welcome distraction during a dark period in Kathy’s life. For two years, her older brother had been suffering from an unknown illness that was slowly robbing him of his ability to travel and play golf, something he loved. It left him weak and dizzy. Even the simplest movements, like walking or climbing stairs, became difficult.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/768/0*AFXDo4DUiFBPD3AQ.jpeg" /></figure><p>Desperation drove him from one specialist to the next — an ear, nose, and throat physician, a cardiologist, a neurosurgeon, a pulmonologist, and finally, a neurologist. But no one could identify the cause of his decline. His doctors were stumped.</p><p>“He was disintegrating,” Kathy recalled. “And no one could figure out why.”</p><p><strong>A promising clue</strong></p><p>Then a life-changing alert appeared on Kathy’s phone.</p><p>“One day, I got a message on my phone from 23andMe about a new genetic health risk report,” she said.</p><p>She logged in and clicked on her Hereditary Amyloidosis (TTR-Related) Genetic Health Risk report* and saw that she had a variant that increased her risk of developing the condition.</p><p>“I didn’t think much of [my reports] at first,” Kathy said. But she decided to share the report with her brother, who then shared it with his neurologist at the University of Massachusetts in Worcester.</p><p>As the neurologist combed through the 23andMe reports, her eyes lit up. “I think this might be what you have,” the neurologist told him. “You need to see a geneticist.”</p><p><strong>Finally, a breakthrough</strong></p><p>Genetic testing confirmed the neurologist’s hunch: Kathy’s brother had<a href="https://www.23andme.com/topics/health-predispositions/hereditary-amyloidosis/"> TTR-related hereditary amyloidosis</a>.</p><p>TTR-related hereditary amyloidosis is a rare genetic condition caused by the build-up of a protein called transthyretin (TTR) in the body’s tissues and organs. This protein build-up, called amyloidosis, can damage the nerves, the heart, and other parts of the body.Symptoms vary widely and depend on how much–and where–the build-up of protein occurs. Because the condition can manifest in so many ways,<a href="https://www.ncbi.nlm.nih.gov/books/NBK1194/"> misdiagnosis</a> is common.</p><p><strong>Slow improvement</strong></p><p>A doctor referred Kathy’s brother to the Boston Amyloidosis Center, where he now receives an intravenous infusion of medication every three weeks to manage his symptoms.</p><p>“Right now there’s no cure, but he’s gained back 40 percent of his movement,” Kathy reported. Simply walking up steps or getting in and out of the car independently and other small milestones are cause for celebration.</p><p>“He’s getting better a little bit at a time. It’s no longer a death sentence,” she said.</p><p>Kathy and the rest of her siblings underwent clinical genetic testing for TTR-related hereditary amyloidosis. Her younger sister also learned that she has the same variant, which puts her at increased risk of developing the condition.</p><p>Though symptom-free, they travel to Boston regularly for testing and checkups. “We’re famous [at the Amyloidosis Center],” Kathy joked. “When we go, they know exactly who we are–we’re the ones with the 23andMe history!”</p><p><strong>Writing a new chapter</strong></p><p>Faced with these unexpected and challenging findings, Kathy and her siblings chose to write a new chapter in their family story. And they’ll share it with anyone who will listen.</p><p>“Love of family and curiosity started this journey,” Kathy explained. “If someone else hears this story and it saves another family–why not tell it?”</p><p><em>*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. The TTR-related hereditary amyloidosis genetic health risk report is indicated for reporting of V122I, V30M, and T60A variants in the TTR gene and describes if a person has variants associated with an increased risk of developing TTR-related hereditary amyloidosis. The majority of the variants included in this report have been most studied in people of African Americans, West African, Portuguese, Northern Swedish, Japanese, Irish, and British descent.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f099194e9829" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/a-sisters-gift-f099194e9829">A Sister’s Gift</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Large, Genetically Diverse Study Identifies 2,300 Genetic Variants Associated with Smoking and…]]></title>
            <link>https://medium.com/23andme-stories/large-genetically-diverse-study-identifies-2-300-genetic-variants-associated-with-smoking-and-823ce7cd71d?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/823ce7cd71d</guid>
            <category><![CDATA[alcohol]]></category>
            <category><![CDATA[tobacco]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Thu, 15 Dec 2022 21:55:25 GMT</pubDate>
            <atom:updated>2022-12-15T21:55:24.924Z</atom:updated>
            <content:encoded><![CDATA[<h3>Large, Genetically Diverse Study Identifies 2,300 Genetic Variants Associated with Smoking and Drinking Behavior</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/902/1*ANYmuWeBGVDaIMxfo3Cbtg.png" /></figure><p>A genome-wide association study of almost 3.4 million people with diverse ancestries has identified 3,823 genetic variants linked to alcohol and tobacco use.</p><p>Published in<a href="https://www.nature.com/articles/s41586-022-05477-4"> <em>Nature</em></a>, the research was led by a team from the University of Minnesota, Minneapolis, and Pennsylvania State College of Medicine and collaborators from industry and other academic institutions.</p><p>The study incorporated the genetic data of almost 3.4 million people with African, American, East Asian, and European Ancestry. Participants were from 60 different cohorts across the globe, including consented research participants from 23andMe.</p><p>This is the first study of its kind to include such a diverse population. It updates <a href="https://www.nature.com/articles/s41588-018-0307-5">work </a>done by the same team in 2019 that primarily relied on data from people of European Ancestry.</p><p><strong>Genetic architecture of substance use</strong></p><p>Smoking and drinking are leading causes of mortality worldwide and are risk factors for many chronic conditions and psychiatric disorders. Though both behaviors can be influenced by environment and culture, evidence suggests genetics plays a role, too.</p><p>The researchers identified 3,823 genetic variants from more than 2,000 genomic regions linked with smoking or drinking traits. More than 2,400 were associated with the likelihood of ever smoking regularly, 243 with the number of cigarettes smoked per day, and 849 with the number of alcoholic drinks consumed per week.</p><p>When they compared these genetic variants across the different ancestries, they found striking similarities, indicating that “the genetic architecture underlying substance use is not markedly different across ancestries.”</p><p>However, they also noted that polygenic risk scores (DNA-based tools that enhance the ability to predict the risk of certain diseases) developed from people of European Ancestry couldn’t accurately predict alcohol and tobacco use in people of other ancestries.</p><p><strong>Diversity is key</strong></p><p>Beyond furthering the understanding of substance use and related behaviors, this work also shows how diverse population samples can increase the scope and power of genetic research.</p><p>Working with an expanded database allowed the researchers to pinpoint more genetic variants that are strongly linked to alcohol and tobacco use. And by including population samples from a wide variety of ancestry groups, these gene variants were able to be found more quickly.</p><p>“Our results highlight that inclusion of individuals of diverse genetic ancestries allows for a better understanding of the genetic architecture of substance use by increasing power to detect variants associated with these behaviors and by improving the generalizability of our findings,” said <a href="https://experts.umn.edu/en/persons/gretchen-r-saunders">Gretchen Saunders</a>, a psychologist at the University of Minnesota, Minneapolis, and a co-author of the paper.</p><p>“As we continue to expand [upon this research], we hope to further include individuals who better represent overall global diversity which would allow for the creation of more equitable genetic risk scores, for example.”</p><p>You can read the full paper <a href="https://www.nature.com/articles/s41586-022-05477-4">here</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=823ce7cd71d" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/large-genetically-diverse-study-identifies-2-300-genetic-variants-associated-with-smoking-and-823ce7cd71d">Large, Genetically Diverse Study Identifies 2,300 Genetic Variants Associated with Smoking and…</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[More On 23andMe’s First Clinical Trial of a Potential New Cancer Treatment]]></title>
            <link>https://medium.com/23andme-stories/more-on-23andmes-first-clinical-trial-of-a-potential-new-cancer-treatment-ecb6fd8488e8?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/ecb6fd8488e8</guid>
            <category><![CDATA[research]]></category>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[clinical-trials]]></category>
            <category><![CDATA[therapeutics]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Tue, 13 Dec 2022 17:32:36 GMT</pubDate>
            <atom:updated>2022-12-13T17:31:57.491Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*duJjK-GjHRJ205MpvfL2cQ.png" /></figure><p>Scientists from 23andMe’s Therapeutics organization recently presented details on the study design of the company’s ongoing Phase 1 clinical trial for a potential new cancer treatment, an immunotherapy antibody called 23ME-00610.</p><p>The details on the types of cancers to be included in an expansion phase of the company’s clinical trial were presented this month at the annual meeting of the Society for Immunotherapy of Cancer (SITC) in Boston.</p><p>The Phase 1 clinical trial is designed to assess the safety and blood levels of 23ME-00610 in patients with advanced solid tumors whose cancer has come back or continued to spread after having taken all available treatments.</p><p>23ME-00610 is an antibody that targets a receptor called CD200R1 expressed on T-cells and myeloid cells, and may restore those cells’ ability to kill cancer cells in patients.</p><p><strong>Trials in progress</strong></p><p>The details presented at SITC were in a “Trials-in-Progress” poster, and included the specific types of tumors that will be studied in this trial. Patients with certain kinds of cancer will be enrolled into the clinical trial in the coming months.</p><p>23andMe is looking to enroll patients with clear cell renal cell carcinoma; epithelial ovarian, fallopian tube or primary peritoneal carcinoma; neuroendocrine cancers including small cell lung cancer; and microsatellite instability-high (MSI-H) or tumor mutational burden-high (TMB-H) cancers that have progressed on standard therapies.</p><p><strong>A Phase I clinical trial</strong></p><p>A Phase 1 clinical trial is meant to assess safety and identify a dose level and dosing frequency for newly developed drug candidates.</p><p>Typically a Phase 1 clinical trial includes a small group of patients who receive the investigational drug. Following close safety monitoring and analysis of drug levels in patients, if the compound is deemed to be well-tolerated, a higher dose of the drug is administered, either within the same group or a separate group of patients. When an appropriate dose level and dosing frequency has been identified, additional patients are typically enrolled to better assess that dose level.</p><p>The plan for this Phase 1 study is to enroll about 100 patients. 23andMe plans to present the results of this clinical trial at an upcoming scientific conference.</p><p><strong>The power of big data</strong></p><p>23andMe has more than 13 million genotyped customers, 80 percent of whom have consented to participate in research. Scientists are able to study the aggregate, de-identified genetics of these millions of participants.</p><p>Pairing this data alongside more than 4 billion self-reported health data points, our scientists use sophisticated analyses to identify potential drug targets. 23andMe has one of the largest research platforms for therapeutic discovery. To date, the 23andMe Therapeutics division has initiated more than 50 therapeutic programs, including 23ME-00610.</p><p>“Our hypothesis, backed by published research, is that drug targets based on human genetics are at least twice as likely to become successful medicines than those with no underlying human genetic evidence,” said Dr. Jennifer Low, Head of Therapeutics Development at 23andMe. “We hope that 23ME-00610 will ultimately show clinical benefit to patients with a number of types of cancer.”</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ecb6fd8488e8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/more-on-23andmes-first-clinical-trial-of-a-potential-new-cancer-treatment-ecb6fd8488e8">More On 23andMe’s First Clinical Trial of a Potential New Cancer Treatment</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The APOE Gene and Alzheimer’s Risk]]></title>
            <link>https://medium.com/23andme-stories/the-apoe-gene-and-alzheimers-risk-58f29798b0a5?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/58f29798b0a5</guid>
            <category><![CDATA[apoe4]]></category>
            <category><![CDATA[alzheimers]]></category>
            <category><![CDATA[alzheimers-disease]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Mon, 05 Dec 2022 20:26:31 GMT</pubDate>
            <atom:updated>2022-12-05T20:24:48.087Z</atom:updated>
            <content:encoded><![CDATA[<p>An Australian actor’s <a href="https://www.vanityfair.com/hollywood/2022/11/chris-hemsworth-exclusive-interview-alzheimers-limitless">recent announcement </a>that he has two copies of the <em>APOE</em>4 variant — which is linked to an increased risk of developing<a href="https://www.23andme.com/topics/health-predispositions/late-onset-alzheimers/"> late-onset Alzheimer’s disease</a> — has been making headlines all over the world.</p><p>There are actually two types of Alzheimer’s disease: late-onset and early-onset. Late-onset Alzheimer’s is the most common, with symptoms of memory loss, cognitive decline, and personality changes beginning after the age of 65.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/435/1*HnmzWCdNHdTYE0ZxM6SjYQ.jpeg" /></figure><p>In the United States alone, about<a href="https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf"> 6.5 million people</a> age 65 and older are living with late-onset Alzheimer’s. And that figure is expected to almost <a href="https://www.alz.org/media/documents/alzheimers-facts-and-figures.pdf">double</a> by 2050.</p><p><strong>Understanding Alzheimer’s</strong></p><p>Late-onset Alzheimer’s is progressive, which means it develops over time. Early stages may result in mild cognitive impairments beyond what would be expected as a natural result of aging.</p><p>According to the CDC, <a href="https://www.cdc.gov/aging/healthybrain/ten-warning-signs.html">symptoms</a> of Alzheimer’s can include:</p><ul><li>Memory loss that disrupts normal life.</li><li>Challenges in planning or solving problems.</li><li>Difficulty completing familiar tasks at home, at work, or at leisure.</li><li>Confusion with time or place.</li><li>Trouble understanding visual images and spatial relations.</li><li>New problems with words in speaking or writing.</li><li>Misplacing things and losing the ability to retrace steps.</li><li>Decreased or poor judgment.</li><li>Withdrawal from work or social activities.</li><li>Changes in mood and personality.</li></ul><p>In later stages, as the disease becomes more severe, these symptoms may become more pronounced, and daily functioning can be severely impaired.</p><p><strong>What are the causes?</strong></p><p>Late-onset Alzheimer’s disease is influenced by genetics, but genetics is only one component of why some people develop the condition.</p><p>Researchers believe that a combination of genetic, environmental, and lifestyle factors all play a role.</p><p><strong>The <em>APOE</em>4 connection</strong></p><p>The <em>E</em>4 variant in the <em>APOE</em> gene is the most common genetic variant associated with an increased risk of developing late-onset Alzheimer’s disease. Having one copy increases the risk by around threefold. Two copies of the <em>APOE</em>4 gene increase risk by around<a href="https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf"> eight-to 12-fold</a>, although the impact of the<em> E</em>4 variant on risk may vary based on a person’s ethnicity.</p><p>The <em>APOE</em> gene is involved in making a protein called apolipoprotein E, which helps control the levels of cholesterol and fats in the blood. It is not known exactly how the <em>E</em>4 variant increases the risk of late-onset Alzheimer’s disease.</p><p>It’s important to note that having one or two copies of the <em>E</em>4 variant does not mean that you will necessarily develop late-onset Alzheimer’s disease. There are other genetic and non-genetic factors that also play a role, including age, family health history, sex, heart health, and ethnicity.</p><p><strong>How can I find out if I have an increased genetic risk?</strong></p><p>You can find out whether you may have an increased risk of developing late-onset Alzheimer’s disease based on your genetics with the 23andMe <a href="https://you.23andme.com/reports/ghr.alzheimers/">Late-Onset Alzheimer’s Disease Genetic Health Risk report</a>*, which looks for the <em>E</em>4 variant.</p><p>According to our data, <em>APOE</em> is among the most sought-after reports by consumers pursuing their own genetic testing. And research suggests there might be a benefit to knowing your genetic status. A study published in<a href="https://www.gimjournal.org/article/S1098-3600(21)02602-2/fulltext"> <em>Genetics in Medicine</em></a><em> </em>found that while some consumers experienced adverse short-term psychological reactions to receiving <em>APOE </em>results, nearly all experienced long-term benefits from receiving this information and making subsequent lifestyle changes.</p><p><strong>How can I reduce my risk of developing Alzheimer’s?</strong></p><p>While there is currently <a href="https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf">no cure</a> for Alzheimer’s, there are six FDA-approved drugs on the market for those who have the condition. Most of these drugs are focused on easing symptoms. However, research suggests it’s possible to reduce your overall risk of developing the disease by making lifestyle changes.</p><p>For example, several<a href="https://aaic.alz.org/releases_2019/AAIC19-Wed-release-NewResearch.asp"> 2019 studies</a> found that healthy lifestyle habits like exercise, healthy diet, abstaining from smoking, and cognitive stimulation were associated with a lower risk of developing the disease.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=58f29798b0a5" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/the-apoe-gene-and-alzheimers-risk-58f29798b0a5">The APOE Gene and Alzheimer’s Risk</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Genetic Conversation Starters for the Thanksgiving Table]]></title>
            <link>https://medium.com/23andme-stories/genetic-conversation-starters-for-the-thanksgiving-table-5fd8536e57dc?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/5fd8536e57dc</guid>
            <category><![CDATA[neanderthals]]></category>
            <category><![CDATA[thanksgiving]]></category>
            <category><![CDATA[genetics]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Tue, 29 Nov 2022 18:38:04 GMT</pubDate>
            <atom:updated>2022-11-29T18:37:54.907Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ool4WjVzCn3-p9NfQIyDLQ.png" /></figure><p>You’re not sure there’s enough turkey to go around, everyone’s had a little too much to drink, and you’re stuck making small talk with a third cousin you just met.</p><p>When you’re gathered around the Thanksgiving table with friends and relatives of all generations, you don’t want to add to your stress by dredging up old family dramas or bringing up potentially divisive topics.</p><p>So we’ve compiled some safe subjects that capture the holiday spirit and remove stress from the menu–from Neanderthal families to the genetics of gratitude. Consider them three secret ingredients for an interesting–and conflict-free-dinner conversation.</p><p><strong>Family ties</strong></p><p>In the past several decades, we’ve learned quite a bit about Neanderthals, our closest extinct human relative who disappeared roughly 40,000 years ago.</p><p>There’s evidence that Neanderthals used tools, created art, and, as a result of interbreeding with modern humans, left a<a href="https://blog.23andme.com/articles/why-23andme-love-neanderthals-and-you-should-too/"> genetic legacy</a> that impacts many of us today.</p><p>And a new discovery suggests they may even have shared some of our social structures.</p><p>An international research team<a href="https://www.nature.com/articles/s41586-022-05283-y"> identified</a> the first known Neanderthal family: a father, his teenage daughter, and others who appear to be close cousins.</p><p>The family was found alongside stone tools and bison bones in Chagyrskaya Cave, located in the Altai Mountains near the Russian border with Kazakhstan, Mongolia, and China.</p><p>??Researchers used the DNA from vertebrae, teeth, and other bones to learn more about this Neanderthal family–from their social organization to their migration and interaction patterns.</p><p>They found very little genetic diversity within this clan, suggesting that Neanderthals in this area lived in small groups.</p><p>But they did discover a high degree of diversity in the mitochondrial DNA passed from mothers to their children. This indicates that these Neanderthal women tended to leave the group where they were born and move from band to band. <br>Spur some dialogue this Thanksgiving by contemplating the role our distant Neanderthal cousins played in the human story. You can even view and compare evidence of Neanderthal ancestry in your genome with 23andMe’s <a href="https://customercare.23andme.com/hc/en-us/articles/212873707-Neanderthal-Ancestry-Report-Basics#:~:text=With%20the%20Neanderthal%20Ancestry%20Report,ancestor%20and%20then%20converged%20again.">Neanderthal Report</a>.</p><p><strong>Cheers</strong></p><p>Why does a glass of cabernet turn your cheeks red but only makes your opinionated uncle louder? Look to the <a href="https://www.23andme.com/topics/wellness/alcohol-flush-reaction/">ALDH2 gene</a>, which contains instructions for making a protein that helps the body process alcohol.</p><p>When we drink, a toxin called acetaldehyde is produced as the body breaks down the alcohol. The body then clears out this toxin by breaking it down further.</p><p>In people with a particular ALDH2 genetic variant, this enzyme is less efficient at clearing away acetaldehyde than in people without the variant, which can result in what’s known as the alcohol flush reaction and other unpleasant symptoms like nausea and sleepiness.</p><p>The variant is most common in individuals with East Asian ancestry. Scientists believe the alcohol flush variant first appeared in ancient China due to a random genetic mutation and spread to neighboring regions as people migrated.</p><p>When you’re passing the wine around this year, consider how your genetic makeup can influence your tastes and preferences. And you might even think about serving a good non-alcoholic drink option, too.</p><p><strong>The genetics of gratitude</strong></p><p>Thanksgiving offers a moment to pause–take stock–and be grateful for what we have. But some may find it easier to feel and express gratitude than others.</p><p>Genetics may help explain that gap.</p><p>In a study published in<a href="https://pubmed.ncbi.nlm.nih.gov/24396004/"> <em>Social Cognitive and Affective Neuroscience</em></a>, researchers from the University of North Carolina and Ohio State found that specific variants in the CD38 gene were associated with the quality and frequency of expressions of gratitude toward a romantic partner both in the lab and in daily life.</p><p>The CD38 gene is a regulator of oxytocin release and social processes. <a href="https://www.google.com/search?q=23andme+blog+oxytocin&amp;oq=23andme+blog+oxytocin&amp;aqs=chrome..69i57j33i160.2940j0j7&amp;sourceid=chrome&amp;ie=UTF-8">Oxytocin</a> is a neuropeptide that impacts pro-social behaviors like trust and affection. It’s involved in all social interactions–from caring for an infant to hugging a romantic partner.</p><p>COMT may be another gene that influences gratitude. A<a href="https://www.sciencedirect.com/science/article/abs/pii/S0165032716316329?via%3Dihub"> 2017 study</a> revealed that individuals with one version of this gene experienced more gratitude, while people with another variant reported feeling less grateful.</p><p>Whether you’re genetically disposed to appreciation or not, there’s still a slew of well-documented benefits for giving thanks around the table, including higher levels of self-reported<a href="https://www.tandfonline.com/doi/abs/10.1080/17439760.2011.602099"> well-being</a> and better<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489271/"> physical health</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5fd8536e57dc" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/genetic-conversation-starters-for-the-thanksgiving-table-5fd8536e57dc">Genetic Conversation Starters for the Thanksgiving Table</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Anxiety and Depression Raise the Risk for Long COVID]]></title>
            <link>https://medium.com/23andme-stories/anxiety-and-depression-raise-the-risk-for-long-covid-951ca2310e65?source=rss----5ff813981120---4</link>
            <guid isPermaLink="false">https://medium.com/p/951ca2310e65</guid>
            <category><![CDATA[covid19]]></category>
            <category><![CDATA[depression]]></category>
            <category><![CDATA[anxiety]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[genetics]]></category>
            <dc:creator><![CDATA[23andMe]]></dc:creator>
            <pubDate>Tue, 29 Nov 2022 16:37:01 GMT</pubDate>
            <atom:updated>2022-11-29T16:37:01.842Z</atom:updated>
            <content:encoded><![CDATA[<p><em>By Catherine Weldon and Stella Aslibekyan, Ph.D.*</em></p><p>In what is among the largest studies of long COVID to date, researchers at 23andMe confirm that it disproportionately impacts women, and being diagnosed with depression or anxiety is associated with a more than a two-fold increase in risk for the condition. The study also found that about half of those with persistent symptoms are experiencing them for six months or longer.</p><p>Even after a year, more than 10 percent of those who reported being diagnosed with long COVID continue to have symptoms like brain fog, fatigue, and shortness of breath. It’s important to note long COVID refers to individuals who have health effects that linger weeks, months, or longer after COVID-19 infection.</p><p>In regression analyses controlling for age, sex, and ethnicity, 23andMe researchers found that those who reported that they had depression or anxiety prior to COVID-19 infection had a two-fold increase in the risk of being diagnosed with long COVID, and having a cardiometabolic disease was associated with a 90 percent higher risk of being diagnosed. Cardiometabolic diseases include conditions such as high blood pressure, coronary artery disease, type 2 diabetes, and high cholesterol.</p><p>23andMe data also indicate that more than half of the participants saw no difference after vaccination. Of those who did see a difference, approximately twice as many people reported improvement rather than worsening of some or all symptoms.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*qXfKXtFeBF9DFalwZQGFug.png" /></figure><h4><strong>Confirms Some Previous Findings</strong></h4><p>Preliminary data from the unpublished study indicates that women are at least twice as likely to be diagnosed with long COVID compared to men even when controlling for age, ethnicity, and related health conditions. This contrasts with the overall breakdown of those infected with COVID-19, where<a href="https://link.springer.com/article/10.1007/s42399-020-00341-w"> men are much more likely</a> to be infected than women. Men are slightly more likely to die from the virus as well, according to a<a href="https://www.sciencedirect.com/science/article/pii/S0277953622000193#!"> recent Harvard study</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*UUL1yOw0JV1_wvxAp073tA.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Epvk42Vpt7e1TO4CH2AwpA.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*gR23VulU14BLBu-ctqK8aw.jpeg" /></figure><p>The 23andMe study data is also consistent with<a href="https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00629-7/fulltext"> other studies</a> that have found women are much more likely to develop long COVID. More than 78 percent of those diagnosed with long COVID in the study were females, compared to about 62 percent among those who reported not having experienced long COVID. The findings in our study are aligned with other studies, including a <a href="https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00629-7/fulltext">study</a> led by researchers at the University of Milan that found that women were more than three times as likely to develop long COVID than men.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fe.infogram.com%2F7b72180c-ccc0-47ea-90f4-521d95bdc53d%3Fsrc%3Dembed&amp;display_name=Infogram&amp;url=https%3A%2F%2Finfogram.com%2Flong-covid-1hdw2jp509g7p2l&amp;image=https%3A%2F%2Finfogram-thumbs-1024.s3-eu-west-1.amazonaws.com%2F033a3600-c532-4b02-8313-2d8577b125c5.jpg&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=infogram" width="690" height="600" frameborder="0" scrolling="no"><a href="https://medium.com/media/65469497d3152aa9bcb8ad71e0eae879/href">https://medium.com/media/65469497d3152aa9bcb8ad71e0eae879/href</a></iframe><p>23andMe’s data also indicated that when compared with men, a larger percentage of women with long COVID appear to have symptoms that persist a bit longer, which is also consistent with<a href="https://www.liebertpub.com/doi/10.1089/jwh.2021.0411"> other smaller studies</a>. In addition, long COVID disturbs menstrual cycles; according to 23andMe’s data, about a quarter are reporting that they are still dealing with disruptions after a year.</p><p>Beyond the disproportionate impact on women, those who have had the most severe cases of COVID are also at a much higher risk of developing long COVID. In the 23andMe study, researchers found that individuals with COVID who required hospitalization had a more than ten-fold risk of being diagnosed with long COVID compared to those who were not hospitalized when controlling for age, sex, and ethnicity.</p><h4><strong>Very Large Study Cohort</strong></h4><p>Scientists still don’t understand what causes long COVID, nor how to best treat it. An effort to recruit patients to study the condition by the National Institutes of Health got off to a slow start, with the agency only recruiting about 1,300 people by late March, far short of their 40,000-patient goal.</p><p>The 23andMe study included data from more than 100,000 individuals who reported contracting COVID-19. Of those included in this study, more than 26,000 reported that they had experienced long COVID, and over 7,000 said they’d been diagnosed with it. This unpublished study is part of <a href="https://blog.23andme.com/tag/covid-19/">a series of studies</a> being conducted by 23andMe scientists since the beginning of the pandemic in 2020.</p><p>Among the areas of study is research on <a href="https://blog.23andme.com/23andme-research/23andme-covid-study-published/">the role blood type plays</a> in severity and susceptibility to the virus, and insights into the genetics that influence <a href="https://blog.23andme.com/23andme-research/reaction-to-covid-vaccine/">different reactions</a> to COVID-19 vaccines. Earlier this year, 23andMe published a study in the journal<a href="https://www.nature.com/articles/s41588-021-00986-w"> <em>Nature Genetics</em></a> that identified genetic variants associated with the loss of smell or taste due to COVID-19. That paper offers more detail on the study, which identified variants near two olfactory genes — <em>UGT2A1</em> and <em>UGT2A2</em>.</p><h4><strong>Long-Haulers and Sex Differences</strong></h4><p>This latest study is part of an effort to better understand the so-called<a href="https://www.nature.com/articles/s41592-021-01145-z"> long haulers</a>: individuals with health effects that linger weeks, months, or longer after COVID-19 infection.</p><p>Why do some individuals continue to have symptoms long after the initial infection? Why are women more likely to develop long COVID than men, and what is the role of genetics in this?</p><p>While the 23andMe researchers found no genetic variants associated with developing long COVID, the higher rate of cases in women may be indicative of differences in hormonal levels, which are substantially rooted in genetics.</p><p>The sex differences do suggest biological underpinnings and can help elucidate them.</p><p>Scientists know there are similar differences for other kinds of conditions. For example, women are much more likely than men to develop autoimmune conditions such as lupus or multiple sclerosis. Autoimmune conditions occur when the body’s immune system misfires and attacks healthy cells in the body. Females typically have two copies of the X chromosome, which has the largest number of immune-related genes. That in turn means that different immune responses are more pronounced in women.</p><p>Whether this explains the much higher incidence of long COVID in women has yet to be determined. But 23andMe researchers did find that about a third, or 32 percent, of those diagnosed with long COVID had some sort of autoimmune disease, compared to only about 20 percent among those who reported not having experienced long COVID.</p><h4><strong>Serious Symptoms</strong></h4><p>Although trend lines are pointing downward for infections, hospitalizations, and deaths due to COVID-19, the impact of long COVID remains unknown. The condition is thought to affect as many as <a href="https://www.bmj.com/content/373/bmj.n1626">30 percent</a> of those who are infected with the virus.</p><p>23andMe’s study found that symptoms lasted from three months to more than a year, with some individuals continuing to suffer. The top symptoms– which the participants reported arose only after the COVID-19 infection– were brain fog, fatigue, and shortness of breath.</p><p>Among those diagnosed with COVID-19, even at six months about 34 percent of those diagnosed with the condition reported an inability to focus or concentrate associated with what’s termed “brain fog.” After a year, about 19 percent still had brain fog. After 12 months, about 14 percent reported having shortness of breath, and about 7 percent said they had heart palpitations.</p><h4><strong>What’s Next</strong></h4><p>There are a few limitations to our study that we should note. For one, this study relies on self-reported data from 23andMe consented research participants. As with other studies on long COVID, the diagnosis is still nebulous and highly variable, and the reports can be subjective. We include both information from those participants who reported that they were diagnosed with long COVID or simply reported that they had long COVID.</p><p>Another important consideration is that 23andMe’s data is not representative of the U.S. population as a whole. That said, the prevalence of various symptoms is similar to that in the published literature.</p><p>Future studies are warranted to continue documenting the natural history of long COVID over longer time periods. In addition to corroborating our findings, it is possible that future studies of even larger populations will find some genetic underpinnings of the reported symptoms, although the individual effect of each genetic factor is likely to be small.</p><p>As people continue to deal with symptoms of long COVID, using studies like ours to better understand the illness will be increasingly important. Projecting over the millions of individuals worldwide who’ve been infected or are yet to be infected, the public health impact of long COVID is likely to linger for years to come. Understanding the underlying biology and associations may help as scientists wrestle with the best way to treat the condition.</p><ul><li><strong><em>Among the largest</em></strong> <strong><em>long COVID studies</em></strong><em> to date using self-reported data from more than 100,000 individuals consented to participate in research.</em></li><li><strong><em>Females are more than twice as likely</em></strong><em> to be diagnosed with long COVID compared to males when controlling for age, race/ethnicity, and related health conditions.</em></li><li><strong><em>Long COVID Symptoms linger past 12 months</em></strong><em> among at least 10 percent of those with long COVID.</em></li><li><em>More than half of those with Long COVID had a history of depression, anxiety, or cardiometabolic disease </em><strong><em>prior</em></strong><em> to COVID-19 infection.</em></li><li><em>Having a history of </em><strong><em>depression or anxiety </em></strong><em>was associated with </em><strong><em>more than a two-fold </em></strong><em>increase in the risk of being diagnosed with Long COVID.</em></li><li><em>Having a </em><strong><em>cardiometabolic disease</em></strong><em> is associated with an approximately </em><strong><em>90% higher</em></strong> <em>risk of being diagnosed with long COVID.</em></li><li><em>About </em><strong><em>a third </em></strong><em>of those who develop Long COVID </em><strong><em>have an autoimmune disease</em></strong><em>.</em></li><li><strong><em>More than half</em></strong><em> of the participants saw </em><strong><em>no difference in symptoms after vaccination</em></strong><em>. Of those who did, almost twice as many reported improvement in symptoms compared to those who reported worsening symptoms.</em></li><li><strong><em>Hospitalization</em></strong><em> for COVID led to a </em><strong><em>ten-fold increase</em></strong><em> in the risk of being diagnosed with long COVID.</em></li><li><em>This </em><strong><em>unpublished</em></strong><em> study is part of </em><a href="https://blog.23andme.com/tag/covid-19/"><em>a series of studies</em></a><em> being conducted by 23andMe scientists since the beginning of the pandemic in 2020.</em></li></ul><p><em>Catherine is an associate scientist at 23andMe and Stella is a genetic epidemiologist at 23andMe.</em></p><p><strong><em>Editor’s note: </em></strong><em>Throughout this post we use the word women for simplicity, but the study was actually based on anyone with XX chromosomes. So “women” in our study may include people whose gender identity is different than the sex they were assigned at birth.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=951ca2310e65" width="1" height="1" alt=""><hr><p><a href="https://medium.com/23andme-stories/anxiety-and-depression-raise-the-risk-for-long-covid-951ca2310e65">Anxiety and Depression Raise the Risk for Long COVID</a> was originally published in <a href="https://medium.com/23andme-stories">23andMe Stories</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>